|
Name of alkaloid | | Molecules | | Biological results | Sample type | Year | Author |
|
Noscapine | 1 | HIF-1 | Decrease | Inhibit angiogenesis by downregulating VEFG | U87MG and T98G cell lines | 2006 | Newcomb et al. [97] |
2 | VEGF | Decrease | Inhibit angiogenesis | Human T98 cell lines | 2008 | Newcomb et al. [98] |
3 | VEGF | Decrease | Inhibit angiogenesis | Murine GL261 glioma cell lines | 2008 | Newcomb et al. [98] |
4 | MMP-9 VEGF | Decrease | Inhibit angiogenesis | KBM-5, HL-60, Jurkat, HuT-78, U266, RPMI- 8226, H1299, A293, DU145, and SCC4 cell lines | 2010 | Sung et al. [99] |
5 | VEGF | Decrease | Inhibit angiogenesis | The A549 or H460 cell | 2010 | Chougule et al. [100] |
6 | VEGF | Decrease | Inhibit angiogenesis | Xenografted with H460 tumors (mice) | 2010 | Chougule et al. [100] |
7 | HIF | Decrease | Inhibit angiogenesis | Ovarian cancer cells | 2011 | Su et al. [101] |
8 | NFKB VEGF | Decrease | Inhibit angiogenesis | The human breast cancer cell lines MDA-MB-231 and MDA-MB-468 | 2011 | Chougule et al. [100] |
|
Berberine | 9 | HIF-1 | Decrease | Inhibit angiogenesis by downregulating VEGF | Gastric adenocarcinoma cell line SC-M1 | 2004 | Lin et al. [102] |
10 | VEGF | Decrease | Inhibit angiogenesis | HeLa cell | 2008 | Lin et al. [103] |
11 | VEGF MMP-2 | Decrease | Inhibit angiogenesis | Human umbilical vein endothelial cells | 2009 | Gao et al. [104] |
12 | Mmp-2/9 UPA | Decrease | Inhibit angiogenesis | Squamous cancer cell | 2009 | Ho et al. [105] |
13 | VEGF | Decrease | Inhibit angiogenesis | Hepatocellular carcinoma | 2010 | C. Cheung et al. |
14 | VEGF | Decrease | Inhibit angiogenesis | Hep G2 cell line | 2011 | Jie et al. [106] |
15 | HIF-1 VEGF | Decrease | Inhibit angiogenesis | B16F-10 melanoma cells and C57BL/6 mice | 2012 | Hamsa and Kuttan [107] |
16 | VEGF | Decrease | Inhibit angiogenesis | Xenografted hepatocellular carcinoma (mice) | 2012 | Ruhua [108] |
17 | VEGF | Decrease | Inhibit angiogenesis | Hepatocellular carcinoma | 2012 | Wang et al. |
18 | VEGF | Decrease | Inhibit angiogenesis | Breast cancer | 2013 | Kim et al. [109] |
19 | VEGF | Decrease | Inhibit angiogenesis | HepG2 cells | 2013 | Wang and Ke [110] |
20 | VEGF | Decrease | Inhibit angiogenesis | Human non-small-cell lung cancer | 2013 | Fu et al. [111] |
21 | Mmp-2 UPA | Decrease | Inhibit angiogenesis | Cervical cancer | 2014 | Chu et al.[112] |
22 | VEGF | Decrease | Inhibit angiogenesis | Hepatocellular carcinoma | 2015 | Tsang et al. [113] |
|
Sanguinarine | 23 | VEGF | Decrease | Inhibit angiogenesis | Swine granulosa cell | 2006 | Bianco et al. [114] |
24 | VEGF | Decrease | Inhibit angiogenesis | Endothelial cell line | 2007 | Basini et al. [115] |
25 | VEGF | Decrease | Inhibit angiogenesis | Swine granulosa cells | 2007 | Basini et al. [116] |
26 | VEGF | Decrease | Inhibit angiogenesis | Porcine aortic endothelial cell line | 2007 | Basini et al. [117] |
27 | VEGF | Decrease | Inhibit angiogenesis | Swine ovarian follicles | 2008 | Basini et al. [116] |
28 | ? | ? | Inhibit angiogenesis | B16 melanoma 4A5 cells | 2009 | De Stefano et al. [118] |
29 | VEGF | Decrease | Inhibit angiogenesis | Human A549 lung cancer cells | 2013 | Xu et al. [119] |
30 | VEGF | Decrease | Inhibit angiogenesis | MCF-7 human mammary adenocarcinoma cells | 2013 | Dong et al. [120] |
31 | VEGF | Decrease | Inhibit angiogenesis | S180 sarcoma in mice | 2014 | Du et al. [121] |
32 | HIF-1 | Decrease | Inhibit angiogenesis | Pancreatic cancer | 2015 | Singh et al. [122] |
|
Sinomenine | 33 | VEGF | Decrease | Inhibit angiogenesis | Human synovial sarcoma cells (Hs701.T) | 2006 | Li et al. [123] |
34 | VEGF | Decrease | Inhibit angiogenesis | Umbilical vein endothelial cells (HUVEC) and U2OS cells | 2016 | Xie et al. [124] |
|
Taspine | 35 | VEGF | Decrease | Inhibit angiogenesis | Chicken chorioallantoic membrane (CAM) neovascularization model and CAM transplantation tumor model | 2008 | Zhang et al. [125] |
36 | VEGF | Decrease | Inhibit angiogenesis | Human umbilical vein endothelial cells | 2008 | Zhao et al. [126] |
37 | VEGF | Decrease | Inhibit angiogenesis | Human umbilical vein endothelial cells | 2010 | Zhang et al. [127] |
38 | VEGF | Decrease | Inhibit angiogenesis | Caco-2 cell lines | 2011 | Zhang et al. [128] |
39 | VEGF | Decrease | Inhibit angiogenesis | Human liver cancer SMMC7721 | 2011 | Zhang et al. [129] |
40 | VEGF | Decrease | Inhibit angiogenesis | Chicken chorioallantoic membrane (CAM) and mouse colon tissue | 2012 | Zhang et al. [130] |
41 | VEGF | Decrease | Inhibit angiogenesis | Human cell lines of SMMC-7721, A549, MCF-7, Lovo, and ECV304 | 2012 | Zheng et al. [131] |
42 | VEGF | Decrease | Inhibit angiogenesis | A549 cells lung cancer | 2012 | Lu et al. [132] |
|
Tetrandrine | 43 | PDGF | Decrease | Inhibit angiogenesis | Adjuvant-induced chronic inflammation model of mouse | 1998 | Kobayashi et al. [133] |
44 | VEGF | Decrease | Inhibit angiogenesis | RT-2 glioma RT | 2009 | Chen et al. [134] |
45 | HIF-1 VEGF | Decrease | Inhibit angiogenesis | A rat model corneal neovascularization (CNV) | 2011 | Sun et al. [135] |
46 | HIF-1 VEGF | Decrease | Inhibit angiogenesis | 4T1 tumor bearing mice | 2013 | Gao et al. [136] |
47 | — | — | Inhibit angiogenesis | Human umbilical vein endothelial cells (HUVECs) and the human colon cancer cell line Lovo | 2013 | Qian et al. [137] |
48 | — | — | Inhibit angiogenesis | Liver cancer xenograft model in nude mice | 2015 | Xiao et al. [138] |
|
Brucine | 49 | VEGF TGF-β | Decrease | Inhibit angiogenesis | Murine cannulated sponge implant angiogenesis model | 2011 | Agrawal et al. [139] |
50 | VEGF | Decrease | Inhibit angiogenesis | Ehrlich ascites tumor and human cancer cell line | 2011 | Agrawal et al. [140] |
51 | VEGF | Decrease | Inhibit angiogenesis | Nude mouse model of bone metastasis due to breast cancer | 2012 | Li et al. [141] |
52 | HIF-1 | Decrease | Migration and metastasis and angiogenesis | Hepatocellular carcinoma | 2013 | Shu et al. [142] |
53 | VEGF | Decrease | Angiogenesis | Colon cancer cells | 2013 | Luo et al. [143] |
54 | VEGF | Decrease | Inhibit angiogenesis | Lovo cell | 2013 | Zheng et al. [144] |
55 | VEGF | Decrease | Inhibit angiogenesis | R breast cancer cell line MDA-MB-231 | 2013 | Kechun and Zjauma [145] |
|
Evodiamine | 56 | VEGF | Decrease | Inhibit angiogenesis | Human lung adenocarcinoma cell (CL1 cells) | 2006 | Shyu et al. [146] |
57 | VEGF | Decrease | Inhibit angiogenesis | Breast cancer cell | 2008 | Wang et al. [147] |
58 | HIF | Decrease | Inhibit angiogenesis | Human colon cancer cell | 2015 | Huang et al. [148] |
|
Homoharringtonine | 59 | VEGF | Decrease | Inhibit angiogenesis | Human umbilical vein endothelial cell line (ECV304) | 2004 | Ye and Lin [149] |
60 | VEGF | Decrease | Inhibit angiogenesis | Leukemic cell line (K562) in vitro | 2004 | Ye and Lin [149] |
61 | VEGF | Decrease | Inhibit angiogenesis | Myeloid leukemia cells | 2005 | Fei and Zhang [150] |
62 | HIF | Decrease | Inhibit angiogenesis | K562 cell | 2008 | Li et al. [151] |
|
Matrine | 63 | VEGF | Decrease | Inhibit angiogenesis | Breast cancer cell | 2009 | Yu et al. [152] |
|
Halofuginone | 64 | VEGF MMP | Decrease | Inhibit angiogenesis | BALB/c (nude) mice | 2003 | Gross et al. [153] |
65 | — | — | Inhibit angiogenesis | Metastatic rat brain tumor model | 2004 | Abramovitch et al. [154] |
66 | TGF | Decrease | Inhibit angiogenesis | Polyoma middle T antigen mouse | 2005 | Yee et al. [155] |
67 | TGF-β-1, bFGF, COL1A1, MMP-2, MMP-9, VEGF, and PDGF | Decrease | Inhibit angiogenesis | Xenografted (rat) | 2012 | Jordan and Zeplin [156] |
68 | VEGF MMP TGF-β | Decrease | Inhibit angiogenesis | Acute promyelocytic leukemia mouse model | 2015 | Assis et al. [157] |
|
Capsaicine | 69 | VEGF | Decrease | Inhibit angiogenesis | Endothelial cells in the rat aorta | 2008 | Pyun et al. [158] |
70 | VEGF | Decrease | Inhibit angiogenesis | Non-small-cell lung cancer | 2014 | Chakraborty et al. [159] |
|
Pterogynidine | 71 | — | — | Inhibit angiogenesis | Human umbilical vein endothelial cells (HUVEC) | 2009 | Lopes et al. [160] |
|